AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.

The American Association for Cancer Research, Inc. specializes in advancing scientific communication and dissemination within the oncology research community, with a focus on publishing peer-reviewed, high-impact scientific manuscripts that drive innovation in cancer informatics and translational research. Their core capability lies in managing the editorial and publication lifecycle of complex biomedical content, ensuring rigorous peer review, technical accuracy, and timely release of findings in prestigious scientific journals such as Cancer Discovery. The organization demonstrates deep expertise in scientific publishing workflows, data-driven research communication, and the integration of informatics tools to enhance the accessibility and impact of cancer research findings. Their work bridges the gap between laboratory discovery and clinical application through authoritative, evidence-based publication. The organization has delivered services to the Department of Health and Human Services, primarily supporting the dissemination of critical cancer research outcomes through formal publication channels. This engagement reflects a focused partnership centered on advancing public health knowledge by ensuring high-quality, scientifically validated content reaches the broader research and clinical communities. Their primary industry focus is in scientific and technical publishing, as reflected by the NAICS code 424920, which in practice encompasses the wholesale distribution of scholarly manuscripts and research outputs—though in this context, it signifies the end-to-end management of scholarly content from submission to publication. The organization is positioned as a niche publisher of high-stakes biomedical research, serving the academic, government, and clinical research sectors with precision and scientific integrity. As a nonprofit entity structured under code 8H, the organization operates from Philadelphia, Pennsylvania, with no federal certifications on record. Its government market presence is defined by mission-driven scientific communication rather than commercial contracting, anchoring its role in the federal research ecosystem through knowledge infrastructure rather than procurement volume.